Structure Database (LMSD)

LMSD: Structure-based search results

LM_ID	Common Name	Systematic Name	Formula	Mass	Main Class	Sub Class
LMFA04010004	14-F4-NeuroP	(Z)-6-(3,5-dihydroxy-2-((1E,5Z,8Z)-3- hydroxyundeca-1,5,8-trien-1-yl) cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010010	7-epi-14-F4t-NeuroP	8S,10R,14S-trihydroxy-4Z,12E,16Z,19Z- neuroprostatetraenoic acid-cyclo[7R, 11R]	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010091	ent-14-F4t-NeuroP	(Z)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2- ((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010092	ent-7-epi-14-F4c-NeuroP	(Z)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2- ((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010093	ent-7-epi-14-F4t-NeuroP	(Z)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2- ((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010094	ent-14-F4c-NeuroP	(Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2- ((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010095	ent-14-epi-14-F4t-NeuroP	(Z)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2- ((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010096	ent-7,14-diepi-14-F4c-NeuroP	(Z)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2- ((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010097	ent-7,14-diepi-14-F4t-NeuroP	(Z)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2- ((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010098	ent-14-epi-14-F4t-NeuroP	(Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2- ((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010099	14-epi-14-F4c-NeuroP	(Z)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2- ((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010100	7,14-diepi-14-F4t-NeuroP	(Z)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2- ((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010101	7,14-diepi-14-F4c-NeuroP	(Z)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2- ((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010102	14-epi-14-F4t-NeuroP	(Z)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2- ((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010103	14-F4c-NeuroP	(Z)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2- ((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010105	7-epi-14-F4c-NeuroP	(Z)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2- ((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010106	14-F4t-NeuroP	(Z)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2- ((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8- trien-1-yl)cyclopentyl)hex-4-enoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]